Clinical Trials
31 trialsHRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor
HRYZ Biotech Co.
PD-1 Inhibitor Based Induction Chemotherapy Followed by De-escalation Protocols in OPSCC
Fudan University
Standard Pulsed Radiofrequency Versus Supervoltage Pulsed Radiofrequency Glossopharyngeal Nerve in Oropharyngeal Cancer Pain
National Cancer Institute, Egypt
Swallowing Outcomes and Circulating Tumor DNA in Patients With HPV Related Oropharyngeal Cancer Treated With Transoral Surgery and Reduced Intensity Adjuvant Therapy
Rutgers, The State University of New Jersey
REFLECT
University Medical Center Groningen
Induction Chemotherapy Followed by Surgery for Locally Advanced Head and Neck Cancer
George Washington University
Investigating the Association Between Microbiota and Esophageal/Oropharyngeal Cancer
National Cheng-Kung University Hospital
Comparative Effectiveness Trial of Transoral Head and Neck Surgery Followed by Adjuvant Radio(Chemo)Therapy Versus Primary Radiochemotherapy for Oropharyngeal Cancer
Universitätsklinikum Hamburg-Eppendorf
Bitter Taste Receptors in Oropharynx Cancer
Technische Universität Dresden
NBTXR3 and Radiation Therapy in Treating Patients With Locally Advanced SCC of the Oral Cavity or Oropharynx
Nanobiotix
Anti-EGFR Therapy With IMRT Concurrent Chemoradiotherapy in Locally Advanced OPC Resistant to Induction Chemotherapy
Fudan University
Cell-free Tumor DNA in Head and Neck Cancer Patients
Rigshospitalet, Denmark
Toripalimab Based Induction Chemotherapy Followed by De-escalation Protocols in HPV-related OPSCC
Fudan University
MESRIX-SAFETY
Rigshospitalet, Denmark
Ropivacaine/Dexamethasone and 10% Lignocaine Injection in GPN Block for Intractable Cancer Pain
All India Institute of Medical Sciences
De-escalation Protocols in HPV-related Oropharyngeal Carcinoma in Chinese Populations
Fudan University
PEARL
Velindre NHS Trust
HPV OncoTect™
Gustave Roussy, Cancer Campus, Grand Paris
uPAR PET/CT for Staging Advanced and Localised Oral and Oropharyngeal Cancer
Rigshospitalet, Denmark
Obstructive Sleep Apnea Syndrome After Oropharyngeal Cancer Treatment
Assistance Publique Hopitaux De Marseille
Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer
National Cancer Institute (NCI)
Cisplatin and Gemcitabine in Treating Patients With Advanced Squamous Cell Cancer of the Head and Neck
National Cancer Institute (NCI)
Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer
National Cancer Institute (NCI)
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck Cancer
National Cancer Institute (NCI)
Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck Cancer
National Cancer Institute (NCI)
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
National Cancer Institute (NCI)
Postoperative Radiotherapy According to Molecular Analysis of Surgical Margins of Oral and Oropharyngeal SCC
Gustave Roussy, Cancer Campus, Grand Paris
Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer
The Second People's Hospital of Sichuan
Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer
National Cancer Institute (NCI)
Analgesia of Fibula Free Flap Donor Site by Peri-Neuronal Catheter in Oro-Pharyngeal Carcinoma Surgery
Gustave Roussy, Cancer Campus, Grand Paris
Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.
Trial Form Support S.L.